Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (34)
Raefa Abou Khouzam, Bassam Janji, Jerome Thiery, Rania Faouzi Zaarour, Ali N. Chamseddine, Hemma Mayr, Pierre Savagner, Claudine Kieda, Sophie Gad, Stéphanie Buart, Jean–Marie Lehn, Perparim Limani & Salem Chouaib. (2023) Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy. Seminars in Cancer Biology 97, pages 104-123.
Crossref
Crossref
Emily Maria Ploeg, Isabel Britsch, Anne Paulien van Wijngaarden, Xiurong Ke, Mark Alexander Johannes Martinus Hendriks, Douwe Freerk Samplonius & Wijnand Helfrich. (2023) A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer. Cancers 15:14, pages 3651.
Crossref
Crossref
Andrea M. Chambers, Jiao Wang, Tram N. Dao, Kyle B. Lupo, Paige Veenhuis, Mitchell G. Ayers, Veronika Slivova, Aaron A. Cohen-Gadol & Sandro Matosevic. (2022) Functional expression of CD73 on human natural killer cells. Cancer Immunology, Immunotherapy 71:12, pages 3043-3056.
Crossref
Crossref
Junqi Wang, Xiaolin Liu, Tianqiang Jin, Yuqing Cao, Yu Tian & Feng Xu. (2022) NK cell immunometabolism as target for liver cancer therapy. International Immunopharmacology 112, pages 109193.
Crossref
Crossref
Hamed Hosseinalizadeh, Mehryar Habibi Roudkenar, Amaneh Mohammadi Roushandeh, Yoshikazu Kuwahara, Kazuo Tomita & Tomoaki Sato. (2022) Natural killer cell immunotherapy in glioblastoma. Discover Oncology 13:1.
Crossref
Crossref
Meriem Hasmim, Malina Xiao, Kris Van Moer, Akinchan Kumar, Alexandra Oniga, Michel Mittelbronn, Caroline Duhem, Anwar Chammout, Guy Berchem, Jean Paul Thiery, Marianna Volpert, Brett Hollier, Muhammad Zaeem Noman & Bassam Janji. (2022) SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC. Frontiers in Immunology 13.
Crossref
Crossref
Andrea M Chambers, Kyle B Lupo, Jiao Wang, Jingming Cao, Sagar Utturkar, Nadia Lanman, Victor Bernal-Crespo, Shadia Jalal, Sharon R Pine, Sandra Torregrosa-Allen, Bennett D Elzey & Sandro Matosevic. (2022) Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. eLife 11.
Crossref
Crossref
Lin Ma, Bowen Diao, Zhaoqin Huang, Bin Wang, Jinming Yu & Xiangjiao Meng. (2021) The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation. Cancer Communications 41:12, pages 1314-1330.
Crossref
Crossref
Emily M. Ploeg, Xiurong Ke, Isabel Britsch, Mark A.J.M. Hendriks, Femke A. Van der Zant, Schelto Kruijff, Douwe F. Samplonius, Hao Zhang & Wijnand Helfrich. (2021) Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles. Cancer Letters 521, pages 109-118.
Crossref
Crossref
Julia Beatrice de Araújo, Vanessa Vitória Kerkhoff, Sarah Franco Vieira de Oliveira Maciel & Débora Tavares de Resende e Silva. (2021) Targeting the purinergic pathway in breast cancer and its therapeutic applications. Purinergic Signalling 17:2, pages 179-200.
Crossref
Crossref
Ankita Agrawal & Niklas R. Jørgensen. (2021) Extracellular purines and bone homeostasis. Biochemical Pharmacology 187, pages 114425.
Crossref
Crossref
Kyle Lupo & Sandro Matosevic. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy
349
368
.
Young Ju Jeong, Hoon Kyu Oh, Hye Ryeon Choi & Sung Hwan Park. (2020) Methylation of the NT5E Gene Is Associated with Poor Prognostic Factors in Breast Cancer. Diagnostics 10:11, pages 939.
Crossref
Crossref
Jiao Wang & Sandro Matosevic. (2020) Functional and metabolic targeting of natural killer cells to solid tumors. Cellular Oncology 43:4, pages 577-600.
Crossref
Crossref
Massimo Giuliani & Alessandro Poggi. (2020) Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies. Cells 9:7, pages 1578.
Crossref
Crossref
Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Gene Kurosawa, Yoshikazu Kurosawa, David Alexander, Hiroyuki Tsuda, Tsuneo Saga & Tatsuya Higashi. (2020) Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression. International Journal of Molecular Sciences 21:7, pages 2304.
Crossref
Crossref
Sarah Sasse, Anna Skorska, Cornelia Aquilina Lux, Gustav Steinhoff, Robert David & Ralf Gaebel. (2019) Angiogenic Potential of Bone Marrow Derived CD133+ and CD271+ Intramyocardial Stem Cell Trans- Plantation Post MI. Cells 9:1, pages 78.
Crossref
Crossref
Guan-Min Jiang, Yuan Tan, Hao Wang, Liang Peng, Hong-Tao Chen, Xiao-Jun Meng, Ling-Ling Li, Yan Liu, Wen-Fang Li & Hong Shan. (2019) The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Molecular Cancer 18:1.
Crossref
Crossref
Hongmei Li, Meihua Lv, Baohua Qiao & Xia Li. (2019) Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer. Archives of Gynecology and Obstetrics 299:6, pages 1737-1746.
Crossref
Crossref
Simone de Leve, Florian Wirsdörfer & Verena Jendrossek. (2019) Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy. Frontiers in Immunology 10.
Crossref
Crossref
Zheng Qiao, Xiaoping Li, Nannan Kang, Yue Yang, Chuyuan Chen, Tao Wu, Mingjun Zhao, Yu Liu & Xuemei Ji. (2019) A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy. International Journal of Molecular Sciences 20:5, pages 1057.
Crossref
Crossref
Andrea M. Chambers, Kyle B. Lupo & Sandro Matosevic. (2018) Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells. Frontiers in Immunology 9.
Crossref
Crossref
Andrea M. Chambers, Jiao Wang, Kyle B. Lupo, Hao Yu, Nadia M. Atallah Lanman & Sandro Matosevic. (2018) Adenosinergic Signaling Alters Natural Killer Cell Functional Responses. Frontiers in Immunology 9.
Crossref
Crossref
Reza Khayami, Younes Toroghian, Amirhossein Bahreyni, Afsane Bahrami, Majid Khazaei, Gordon A. Ferns, Safieh Ebrahimi, Anvar Soleimani, Hamid Fiuji, Amir Avan & Seyed Mahdi Hassanian. (2018) Role of adenosine signaling in the pathogenesis of head and neck cancer. Journal of Cellular Biochemistry 119:10, pages 7905-7912.
Crossref
Crossref
Pier Andrea Borea, Stefania Gessi, Stefania Merighi, Fabrizio Vincenzi & Katia Varani. (2018) Pharmacology of Adenosine Receptors: The State of the Art. Physiological Reviews 98:3, pages 1591-1625.
Crossref
Crossref
Asunción Díaz-Serrano, Pablo Gella, Elisabeth Jiménez, Jon Zugazagoitia & Luis Paz-Ares Rodríguez. (2018) Targeting EGFR in Lung Cancer: Current Standards and Developments. Drugs 78:9, pages 893-911.
Crossref
Crossref
Alberto L. Horenstein, Antonella Chillemi, Roberta Zini, Valeria Quarona, Nicoletta Bianchi, Rossella Manfredini, Roberto Gambari, Fabio Malavasi & Davide Ferrari. (2018) Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors. Frontiers in Pharmacology 9.
Crossref
Crossref
L. Buisseret, S. Pommey, B. Allard, S. Garaud, M. Bergeron, I. Cousineau, L. Ameye, Y. Bareche, M. Paesmans, J.P.A. Crown, A. Di Leo, S. Loi, M. Piccart-Gebhart, K. Willard-Gallo, C. Sotiriou & J. Stagg. (2018) Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial. Annals of Oncology 29:4, pages 1056-1062.
Crossref
Crossref
Jiangang Yu, Xue Wang, Qi Lu, Jigang Wang, Luying Li, Xiaohong Liao, Wei Zhu, Lei Lv, Xiuling Zhi, Jerry Yu, Yiting Jin, Qiang Zou, Zhouluo Ou, Xiuping Liu & Ping Zhou. (2017) Extracellular 5′‐nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK‐3β/β‐catenin/cyclinD1 signaling pathway. International Journal of Cancer 142:5, pages 959-967.
Crossref
Crossref
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref
Crossref
Stefania Gessi, Serena Bencivenni, Enrica Battistello, Fabrizio Vincenzi, Vittoria Colotta, Daniela Catarzi, Flavia Varano, Stefania Merighi, Pier Andrea Borea & Katia Varani. (2017) Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455. Frontiers in Pharmacology 8.
Crossref
Crossref
Luca Antonioli, Sergey V. Novitskiy, Kris F. Sachsenmeier, Matteo Fornai, Corrado Blandizzi & György Haskó. (2017) Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies. Drug Discovery Today 22:11, pages 1686-1696.
Crossref
Crossref
Antonella Chillemi, Valeria Quarona, Luca Antonioli, Davide Ferrari, Alberto L. Horenstein & Fabio Malavasi. (2017) Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche. Frontiers in Immunology 8.
Crossref
Crossref
Davide Ferrari, Fabio Malavasi & Luca Antonioli. (2017) A Purinergic Trail for Metastases. Trends in Pharmacological Sciences 38:3, pages 277-290.
Crossref
Crossref